In this way, we found that cultured CLL samples expressed AID mRNA and that production of AID protein varied considerably on a patient basis with the percentages of AID+ cells ranging from ~1 to ~80% (88). Here, AICDA is linked to B-cell chronic lymphocytic leukemia.